期刊
CANCER LETTERS
卷 344, 期 1, 页码 13-19出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2013.10.015
关键词
Tumor model; Xenograft; Preclinical model; Humanized mice; NOD-SCID-IL2rg(-/-) mice; Immunodeficient mice
类别
Humanized mouse models have been developed and utilized in cancer research for decades. Newly developed combined immunodeficient NOD-SCID-IL2rg(-/-) mice are more permissive for human cells and tissue engraftment In this review, we discuss the use of NOD-SCID-IL2re(-/-) mice as a preclinical tool in cancer research and its potential use for individualized cancer therapies. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据